NCT01073163 · Interventional trial
Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)
Overall registry status Completed
Phase 3
Conditions Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma
Delaware Valley sites
- Pennsylvania Oncology Hematology Associates, Inc. · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory